Clinical Trial Update: A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery [Phase 2]

View source ↗

Summary

Phase II trial update comparing SOX (S-1 plus oxaliplatin) vs SP (S-1 plus cisplatin) as adjuvant chemotherapy after D2 gastrectomy in gastric cancer. The statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Peking University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN